VieLight Intranasal Light Therapy 810

VieLight Intranasal Light Therapy 810

Free Shipping
On most orders over $250 within the continental USA
Quantity in stock
940 item(s)
1 unit
Our Price:
Questions? Call 408-354-4262
- or -
  • Details
  • Ingredients
  • Send to friend
  • Related Products
  • Customers Also Bought
  • Customer feedback
  • FAQ

VieLight Intranasal Light Therapy 810

The Vielight 810 is a non-laser intranasal light therapy model. Engineered for gentle brain stimulation, this device complements the systemic effects of the Vielight 633 and 655.

The 810nm near infrared wavelength enables photonic transmission past the intranasal channel to the deep ventral brain areas. Neurons are well-suited for photobiomodulation because they contain mitochondria. 

Before and after QEEG images show the Vielight 810 inducing restorative activity in the brain per 25-minute session. 

Our intranasal devices combine solid state technology along with intranasal diodes built from transparent high impact polycarbonate to ensure quality and durability, turning this into a lifetime investment.

Note for users
– Near-infrared photons are invisible to the naked eye. Additionally, the beam is pulsed at 10 Hz
– Sleepiness is a common side effect of using this device due to the pulse rate correlating with alpha brain waves and neuronal stimulation


Intranasal Light Therapy is a way to stimulate the body to re-establish its natural internal balance. During this process, the wellness of the body is expected to improve, including reports of elevated energy levels and wellness of body and mind.*

The nasal cavity has been found to be a highly convenient and effective way to deliver this effect. Until the invention of the Vielight devices, for a long time, advocates did not think it was possible to achieve this through the nasal cavity.*

The Vielight products have been designed with parameters to deliver the discoveries that have been associated with "blood irradiation". Regular use of the products may improve the quality of life of the user. No claim has been made for a cure, and results vary between users. They have not been evaluated by regulatory authorities*



 633 Red (Qi-Light)

655 Prime Not Currently Available

810 Infrared
Light sourceLEDLow level laserLED
Wavelength633 nm655 nm810 nm
ColorRedDeep redInvisible
Pulse modeContinuousContinuousPulsed at 10 Hz
Battery life2 months3 months2.5 months
Safety issuesNoneVery smallNone
Research studiesFewManyFew
Therapeutic objectivesGeneral wellnessGeneral wellnessDirects more therapeutic lights to the brain.


Intranasal Light Therapy involves the simple process of clipping a small red light diode to the nose to illuminate the nasal cavity. Researchers have found that this act stimulates the body to re-establish the ideal internal body environment. Traditional Chinese medicine (TCM) interprets this as balancing the energy forces (yin / yang).

Scientists who specialise in the stimulation characteristic of light (or “photobiostimulation”) know that a certain wavelength of light with the right energy dosage can safely excite molecules that signal cells to release more energy and other signals to achieve homeostasis. Collectively, the effect becomes systemic. Intranasal Light Therapy starts this effect by illuminating the blood passing through the nasal region which then spread throughout the body through the circulatory and lymphatic systems. Facial areas may also respond directly to the light source*

Homeostatic activities continuously take place inside the body but when inflammation takes place due to an infection or when cellular homeostasis is interrupted , the body’s corrective system is called into action. The signalling stimulated by light therapy as explained here, helps the body to act on a dysfunction (often referred as "negative feedback"). The result may help improve wellness, and hence, one's quality of life.*

No major side effects has been found with photobiostimulation. Nor is there an introduction of a foreign substance into the body. The process merely harnesses the natural abilities of the body.*

Intranasal Light Therapy main advantage over other similar alternatives is its convenience and portability.*

The technology is complementary to medications and dietary supplements in general. There are no significant contraindications and patients often experiment to learn when the right time is to use of the device. It encourages the user to take ownership of his or her own health.*

Intranasal Light Therapy is supported by a large body of scientific evidence, both for the underlying mechanism as well as for demonstrating its effectiveness for improving one’s quality of life. *


In China, intranasal light therapy with low level laser has been used to treat insomnia. Wang et al (2006) treated 50 patients with insomnia with low level laser at 650 nm, powered with 3 mW for 60 minutes per each session per day, over 10 – 14 days. They found that the symptoms improved significantly for 82% of the patients.


Jin L et al (2001) randomly divided 93 patients with cerebral infarction into three groups, 30 in a drugs‐only group (A Group), 32 in intranasal low level laser therapy + drugs group (B Group) and 31 in an intravascular low energy laser therapy + drugs group (C Group), and then treated B Group with low level laser at 670 nm and 7 ‐10 mW for 40 min each time and C Group with He‐Ne (632.8 nm) laser at 1.5 mW for 90 min each time, once daily for ten days. They found a decrease in the peak latency potential of the P300 waveform, and greater erythrocyte deformity after the treatment in either B or C Groups than A



Xu C et al (2002) divided the objects into two groups, 47 patients with Alzheimers disease (AD) and 22 patients with gastric ulcer, and treated the patients with intranasal low level laser therapy with He‐Ne source at 3.5 ‐ 4.5 mW for 30 minutes each time, which was done once every morning for 30 days. They found that melatonin, score in mini‐mental state exam (MMSE) and score in Wechsler memory scale for adult (WMS) increased in the AD group, but there was no significant change for the gastric ulcer group.



Li Q et al (1998) treated 43 patients with Parkinsons disease (PD) with intranasal low level He‐Ne laser therapy at 3.5 ‐ 5.5 mW for 30 minutes per treatment session per day for ten days, and found serum cholecystokinin‐ octapeptide (CCK‐8 ‐ which high levels have a deleterious effect on cognitive ability in PD)4 decreased to normal levels. When referencing to Webster Scale scores (WSS), they found the improvements to be significant for 26 of the 43 patients.

Xu C et al (2003), treated 47 patients with PD with intranasal low level He‐Ne laser therapy at 3.5 to 4.5 mW for 30 minutes per session, every morning for 20 days, and found the PD symptoms improved for 31 (66%) of the patients. Out of these, 14 (29.8%) were significant while 27 (57.4%) were mild. Presence of superoxidase dismutase (SOD) and melatonin increased and malondialdehyde (MDA – a marker for oxidative stress) decreased.

Zhao G et al (2003) treated 36 patients with PD with intranasal low level He‐Ne laser therapy at 3.5 ‐ 5.5 mW for 30 minutes per session per day for ten days, and found improvements in PD symptoms for 31 (89.1%) of the patients; out of whom 10 (27.8%) of them were significant and 21 (58.35) mild.



Liao Z et al (2000) randomly divided 80 patients with schizophrenia into two groups, 40 in drugs‐only group (A Group) and 40 in intranasal low level He‐Ne laser therapy +drugs group (B Group). The B Group was treated with energy of 2 mW for 60 minutes per session per day for ten days. They found that significant improvement was achieved more quickly with the B Group ‐ on the 18th day versus the 26th day for the A Group.


Li Q et al (1998) treated 39 patients with chronic headache, migraine and trigeminal neuralgia with intranasal low level He‐Ne laser therapy at 3.5 ‐ 4.5 mW for 30 minutes per session per day over two 5‐day sessions with a 2‐day break in between. They found improvements in 35 (89.8%) of the patients, out of whom 26(66.7%) were significant. The blood β endorphin in the blood of the 35 improved patients was also found to have increased.


Qiao Y et al (2004) treated 68 patients with cerebral infarction with intranasal low level He‐Ne laser therapy at 10 ‐ 15 mW for 60 minutes per session per day over 10 days. The more severe cases had 3 sessions per day. They found improvements in 61 (89.7%) of the cases, out of which 34 (50.0%) were significant


VieLight Intranasal Light Therapy 810

Recommended Usage:
Use daily in the evening (auto-timed for 25 minutes and hands-free) to maintain good health. However, users are encouraged to experiment to determine the routine that gives the best result for his/her mind and body. Users should not compensate missed daily treatments by doing more treatments in a day.

Use maximum of twice daily (with at least 6 hour break) in a health event.

Built to withstand drop tests and normal use; diode has a specified life of 30,000 hours. Known to survive the weight of a truck.

Our guarantees

We appreciate that the technology is unfamiliar and non-intuitive to many people unless considerable time is invested in researching it. Furthermore, human bodies are different and predisposed in different ways – and there would be some people who would be non-responsive. For this reason, we provide a 6 months, no-question-asked 80% refund if the product does not improve your condition.

We will also replace the product if there is any defect in the product itself, covered by a 12-month warranty.

Safety and Regulations
The devices have been tested for electrical safety and rendered safe. It consumes and generates less energy than most consumer electronic devices, and the energy cannot be felt by a normal person. They are compliant with the European CE requirements for safety. However, they have NOT been evaluated by any regulatory body, including the FDA and Health Canada. The company does not make any claim for long-term cures although the evidence shows that regular use may improve the user’s quality of life. All evidence have been based on actual available data with these devices and/or published evidence based on other tests based on similar parameters and scientific bases.


How To Use Your Intranasal Device

Detailed instructions on how to use your intranasal device.

How To Change Batteries:
Watch this video on how to change batteries in your intranasal device:

An Alternative Way To Open the Battery Cover:
1. Press down hard on the top of the cover, where it joins the top frame.

2. While pressing it down, slide out the cover.

Don’t worry about applying pressure: it won’t break.

This field is required
A valid email is required
A valid email is required
This field is required
There have been no reviews

Add your own review


Based on the US Food and Drug Administration (FDA) information sheets for medical devices, low level laser therapy (LLLT) as well as normal light therapy devices are categorized as “non-significant risk” products.

After more than three decades of research there is no known major side effects attached to these light therapies.

Reported side effects for some first-time users include:

• Tiredness (temporary) – probably due to the release of metabolites but the majority report a resurgence of energy
• Headaches (temporary) – from the reactivation of neural connections and increased microcirculation
• Dry throat (temporary) – from the stimulation of renal functions
• Reactivation of repressed mental trauma – the reactivation of neural connections may trigger repressed traumatic memories to resurface.


Over 40 years of accumulated scientific studies on low level light therapy reveal no major contraindication. However, this therapy is not recommended for use in the presence of cancer tumor in the nasal area ( Nasal polyps on the other hand has responded positively).

Energy Safety Issues

Vielight 633 Red (formerly branded as “Qi-light”) has a non-laser based light source (incoherent light) with very low level intensity. The energy generated is lower than natural light. Its energy output of 8mW is 125 times lower than that of a small flash light with the typical power of 1 W.

Vielight 655 Prime or “RadiantLife LT” has a low intensity laser source that is powered to generate very low and safe energy output. Its energy output of under 5 mW is 200 times lower than that for a small flash light with the typical energy of 1W.

However pointing a laser light to the retina can cause tissue damage and scarring. The danger of this is mitigated by the fact that the 655/RadiantLife laser is not pure, collimated laser: the light is not completely coherent and has some built-in divergence of about 57 degrees. Human involuntary reflex would also cause immediate blinking when the laser light is pointed to the eye. Nevertheless precaution should still always be taken and it should not be handled by children without supervision.

Vielight 810 Infrared has a non-laser (incoherent light) with very low level intensity. The energy generated is lower than natural light. Its energy output of 10 mW is 100 times lower than that of a small flash light with the typical power of 1 W. Users should note that this light is invisible to the naked eye.


1. Tuner J and Horde L. The New Laser Therapy Handbook. Prima Books AB. 2010

  • Disclaimer

*Your results may vary from those listed above.

*These statements have not been evaluated by the Food and Drug Administration.
*This product is not intended to diagnose, treat, cure or prevent any disease.

Since we do not know everything about your medical history and medications, please consult with your health care practitioner before implementing any new protocols and supplements. Do not construe any information listed on this site as a substitute for actual medical advice. The info you receive from us is not intended to replace medical advice by your doctor. Forrest Health, Inc. does not dispense medical advice, prescribe, or diagnose illness. We offer nutritional programs and supplements that support your health. The views and nutritional advice expressed by Forrest Health, Inc. are not intended to be a substitute for conventional medical service. If you have a medical condition, see your physician of choice.